Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells

Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells

US Patent 8771694 · Granted Jul 8, 2014

Estimated economic value: $1,799,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins comprising extracellular domain of human CD222024
Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 a2020
Isolation, detection, diagnosis and/or characterization of circulating Trop-2-po2019
Combination therapy for inducing immune response to disease2019
T-cell redirecting bispecific antibodies for treatment of disease2019
RS7 antibodies2019
Humanized anti-HLA-DR antibodies2019
Nucleic acids encoding chimeric and humanized anti-histone antibodies2018
Combination therapy for inducing immune response to disease2018
Chimeric and humanized anti-histone antibodies2018
RS7 antibodies2018
Therapeutic use of anti-CD22 antibodies for inducing trogocytosis2018